Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00810485 · ClinicalTrials.gov registry record · Phase 2

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

A Phase 2 study of Gastroesophageal Reflux, sponsored by Addex Pharma S.A..

Completed
Registry status
Phase 2
Development phase
298
Enrollment target
20
Study locations

NCT00810485 is a Phase 2 study of Gastroesophageal Reflux that has completed, run by Addex Pharma S.A.. The registered enrollment target is 298 participants, above the 173-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (72% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00810485, a Phase 2 study of Gastroesophageal Reflux, has completed, sponsored by Addex Pharma S.A..

COMPLETED
Registry status
Phase 2
Development phase
298 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the effect of ADX10059 in patients with gastroesophageal reflux disease who are partial responders to proton pump inhibitors

Conditions Studied

Gastroesophageal Reflux

Interventions

  • DRUG ADX10059
  • DRUG ADX10059 Matching Placebo

Study Locations (20)

North Carolina

  • - Harrisburg
  • - High Point
  • - Huntersville
  • - Raleigh
  • - Winston-Salem

Arizona

  • - Little Rock
  • - Tucson

California

  • - Anaheim
  • - San Diego

Florida

  • - Jacksonville
  • - Port Orange

Kansas

  • 54 - Kansas City
  • 62 - Kansas City

Colorado

  • - Colorado Springs

Illinois

  • - Moline

Mississippi

  • - Jackson

Trial Details

FieldValue
Enrollment Target 298 participants
Start Date 2008-12
Phase Phase 2

Sponsor

Addex Pharma S.A.

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00810485

The ClinicalTrials.gov registry entry for NCT00810485 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 173-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (72% higher). The listed sponsor is Addex Pharma S.A., which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 2 interventions - of which ADX10059 is the first listed.

NCT00810485 reports 20 study locations spanning 12 distinct geographic areas - top geographies include North Carolina, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT00810485 about?

NCT00810485 is a clinical study titled "ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)". The purpose of this study is to evaluate the effect of ADX10059 in patients with gastroesophageal reflux disease who are partial responders to proton pump inhibitors

What is the current status of trial NCT00810485?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 298 participants. The study started on 2008-12.

What conditions does trial NCT00810485 study?

This clinical trial studies the following conditions: Gastroesophageal Reflux.

What interventions are being tested in trial NCT00810485?

The interventions under investigation include: ADX10059 (DRUG), ADX10059 Matching Placebo (DRUG).

Who is sponsoring clinical trial NCT00810485?

This trial is sponsored by Addex Pharma S.A., which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00810485 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gastroesophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gastroesophageal Reflux

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.